Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018963167> ?p ?o ?g. }
- W2018963167 endingPage "329" @default.
- W2018963167 startingPage "323" @default.
- W2018963167 abstract "Scleroderma is an autoimmune connective tissue disorder that is characterized by microvascular injury, excessive fibrosis of the skin, and distinctive visceral changes that can involve the lungs, heart, kidneys and gastrointestinal tract. To date, although several drugs have been used to reduce fibrosis in scleroderma, there exists no effective pharmacological treatment. To determine if oral ciprofloxacin reduces the severity of scleroderma, a controlled, double-blind randomized clinical trial, with placebo, was conducted on 32 patients with diffuse and limited scleroderma, who received oral ciprofloxacin (250 mg) or placebo every 12 h. Skin induration and thickness of the patients were clinically evaluated using the modified Rodnan skin score at the beginning and once per month during 6 months of treatment with ciprofloxacin. To monitor progression of the disease, a monthly hematological exam and clinical evaluation was done to explore renal and hepatic function for each patient. Thirty patients completed the study; one from the treatment group was excluded when presenting a skin reaction and another from the placebo group abandoned the study due to an exacerbation of disease. At the sixth month of the study, the ciprofloxacin group of patients showed a diminution in the modified Rodnan skin score (58% vs 18%, P = 0.003), showing no significant alterations in the laboratory assays in either groups of patients. Our results suggest that oral administration of ciprofloxacin for 6 months reduces the severity of symptoms affecting the skin of patients with systemic scleroderma, and does so without important secondary effects." @default.
- W2018963167 created "2016-06-24" @default.
- W2018963167 creator A5006055236 @default.
- W2018963167 creator A5009404210 @default.
- W2018963167 creator A5020368412 @default.
- W2018963167 creator A5031565272 @default.
- W2018963167 creator A5069536365 @default.
- W2018963167 creator A5078370003 @default.
- W2018963167 date "2010-04-01" @default.
- W2018963167 modified "2023-09-25" @default.
- W2018963167 title "Ciprofloxacin utility as antifibrotic in the skin of patients with scleroderma" @default.
- W2018963167 cites W1542691943 @default.
- W2018963167 cites W1981590270 @default.
- W2018963167 cites W1986391515 @default.
- W2018963167 cites W1987415356 @default.
- W2018963167 cites W1988803878 @default.
- W2018963167 cites W2001952538 @default.
- W2018963167 cites W2043180366 @default.
- W2018963167 cites W2048840144 @default.
- W2018963167 cites W2056364917 @default.
- W2018963167 cites W2058661633 @default.
- W2018963167 cites W2074488305 @default.
- W2018963167 cites W2076545156 @default.
- W2018963167 cites W2093667509 @default.
- W2018963167 cites W2100542978 @default.
- W2018963167 cites W2108348699 @default.
- W2018963167 cites W2109096032 @default.
- W2018963167 cites W2113187512 @default.
- W2018963167 cites W2117322594 @default.
- W2018963167 cites W2131014787 @default.
- W2018963167 cites W2133156521 @default.
- W2018963167 cites W2147543851 @default.
- W2018963167 cites W2150190285 @default.
- W2018963167 cites W2170266396 @default.
- W2018963167 cites W2170484142 @default.
- W2018963167 cites W2282701797 @default.
- W2018963167 cites W2415500873 @default.
- W2018963167 cites W2417328942 @default.
- W2018963167 cites W4249067852 @default.
- W2018963167 doi "https://doi.org/10.1111/j.1346-8138.2010.00826.x" @default.
- W2018963167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20507401" @default.
- W2018963167 hasPublicationYear "2010" @default.
- W2018963167 type Work @default.
- W2018963167 sameAs 2018963167 @default.
- W2018963167 citedByCount "8" @default.
- W2018963167 countsByYear W20189631672012 @default.
- W2018963167 countsByYear W20189631672014 @default.
- W2018963167 countsByYear W20189631672015 @default.
- W2018963167 countsByYear W20189631672017 @default.
- W2018963167 countsByYear W20189631672019 @default.
- W2018963167 countsByYear W20189631672023 @default.
- W2018963167 crossrefType "journal-article" @default.
- W2018963167 hasAuthorship W2018963167A5006055236 @default.
- W2018963167 hasAuthorship W2018963167A5009404210 @default.
- W2018963167 hasAuthorship W2018963167A5020368412 @default.
- W2018963167 hasAuthorship W2018963167A5031565272 @default.
- W2018963167 hasAuthorship W2018963167A5069536365 @default.
- W2018963167 hasAuthorship W2018963167A5078370003 @default.
- W2018963167 hasConcept C126322002 @default.
- W2018963167 hasConcept C141071460 @default.
- W2018963167 hasConcept C142724271 @default.
- W2018963167 hasConcept C16005928 @default.
- W2018963167 hasConcept C180032290 @default.
- W2018963167 hasConcept C204787440 @default.
- W2018963167 hasConcept C27081682 @default.
- W2018963167 hasConcept C2776670291 @default.
- W2018963167 hasConcept C2777014857 @default.
- W2018963167 hasConcept C2778512257 @default.
- W2018963167 hasConcept C2779075594 @default.
- W2018963167 hasConcept C2779134260 @default.
- W2018963167 hasConcept C2779625490 @default.
- W2018963167 hasConcept C2779967694 @default.
- W2018963167 hasConcept C2780559512 @default.
- W2018963167 hasConcept C501593827 @default.
- W2018963167 hasConcept C535046627 @default.
- W2018963167 hasConcept C71924100 @default.
- W2018963167 hasConcept C86803240 @default.
- W2018963167 hasConcept C89423630 @default.
- W2018963167 hasConcept C90924648 @default.
- W2018963167 hasConceptScore W2018963167C126322002 @default.
- W2018963167 hasConceptScore W2018963167C141071460 @default.
- W2018963167 hasConceptScore W2018963167C142724271 @default.
- W2018963167 hasConceptScore W2018963167C16005928 @default.
- W2018963167 hasConceptScore W2018963167C180032290 @default.
- W2018963167 hasConceptScore W2018963167C204787440 @default.
- W2018963167 hasConceptScore W2018963167C27081682 @default.
- W2018963167 hasConceptScore W2018963167C2776670291 @default.
- W2018963167 hasConceptScore W2018963167C2777014857 @default.
- W2018963167 hasConceptScore W2018963167C2778512257 @default.
- W2018963167 hasConceptScore W2018963167C2779075594 @default.
- W2018963167 hasConceptScore W2018963167C2779134260 @default.
- W2018963167 hasConceptScore W2018963167C2779625490 @default.
- W2018963167 hasConceptScore W2018963167C2779967694 @default.
- W2018963167 hasConceptScore W2018963167C2780559512 @default.
- W2018963167 hasConceptScore W2018963167C501593827 @default.
- W2018963167 hasConceptScore W2018963167C535046627 @default.
- W2018963167 hasConceptScore W2018963167C71924100 @default.
- W2018963167 hasConceptScore W2018963167C86803240 @default.